Amicus Therapeutics Files 8-K on Financials
Ticker: FOLD · Form: 8-K · Filed: Jul 31, 2025 · CIK: 1178879
| Field | Detail |
|---|---|
| Company | Amicus Therapeutics, Inc. (FOLD) |
| Form Type | 8-K |
| Filed Date | Jul 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
Related Tickers: AMTX
TL;DR
AMTX filed an 8-K on 7/31/25 detailing financial results.
AI Summary
Amicus Therapeutics, Inc. filed an 8-K on July 31, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and headquartered in Princeton, New Jersey.
Why It Matters
This 8-K filing provides crucial updates on Amicus Therapeutics' financial performance and operational results, which can impact investor decisions and stock valuation.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate or significant new risks.
Key Players & Entities
- AMICUS THERAPEUTICS, INC. (company) — Registrant
- July 31, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Princeton, New Jersey (location) — Address of Principal Executive Offices
- 001-33497 (identifier) — Commission File Number
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported was on July 31, 2025.
What is the principal executive office address for Amicus Therapeutics, Inc.?
The principal executive offices are located at 47 Hulfish Street, Princeton, New Jersey 08542.
What is the Commission File Number for Amicus Therapeutics, Inc.?
The Commission File Number is 001-33497.
What is the SIC code for Amicus Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 31, 2025 regarding AMICUS THERAPEUTICS, INC. (FOLD).